JMI’s Matt Emery Honored as one of 2025’s Top Healthcare Investors by GrowthCap
JMI Equity, a growth equity firm focused on investing in leading software companies, is pleased to announce JMI Partner Matt Emery, has been recognized by GrowthCap as among the Top Healthcare Investors of 2025.
Matt was selected based on his distinguished career trajectory, the high regard in which he is held by peers and colleagues, and his professional achievements and performance, all of which were carefully evaluated by GrowthCap.
Matt joined JMI in 2006 and focuses on JMI’s investments in software and healthcare IT businesses. In addition to supporting JMI’s current portfolio companies, he also helps to identify and assess potential investment opportunities in high-growth software companies. Matt has held numerous board positions at JMI portfolio companies during his tenure and currently oversees the investments or serves on the boards of CipherHealth, Clio, Jane Software, PointClickCare, and TimelyCare. He played an active role with investments in Axonify (acquired by Luminate Capital Partners), Capsule Tech (acquired by Qualcomm), Healthx (acquired by Zipari), Navicure (acquired by Bain Capital), and Workfront (acquired by Adobe).
Prior to joining, Matt was an analyst in the technology investment banking group at Thomas Weisel Partners and a research associate at Thompson, Siegel & Walmsley. Matt is a CFA charter holder and graduated from the University of Virginia with a BS in Commerce.
Disclaimer: GrowthCap is a leading growth capital research and advisory firm. The criteria considered for this award is determined by GrowthCap which compiles its annual list by evaluating each nominee’s career experience and evolution, how their peers and colleagues view their capabilities, and their professional performance and milestones achieved. The award is the subjective determination of the party conferring the award and not of JMI Equity. JMI Equity submitted a nomination to be considered for, and once selected, paid to be included on, and to promote inclusion on, this list. JMI Equity received this award in 2025. The time period upon which the award was based is calendar year 2024. For more information about GrowthCap, please see their website at growthcapadvisory.com. JMI is not responsible for the contents of any third-party website and has not confirmed the accuracy of any information provided therein.
